Retrospective cohort study characterizing PD-1/PD-L1 checkpoint inhibition associated Stevens-Johnson syndrome and toxic epidermal necrolysis - 18/10/24
Doi : 10.1016/j.jaad.2024.06.066
Anthony Chen, BA a, Joanna A. Kolodney, MD b, Michael S. Kolodney, MD, PhD a, ⁎ 
a Department of Dermatology, West Virginia University, Morgantown, West Virginia
b Division of Hematology-Oncology, Department of Medicine, West Virginia University, Morgantown, West Virginia
∗Correspondence to: Michael S. Kolodney, MD, PhD, Department of Dermatology, School of Medicine, PO Box 9158, 1 Medical Center Dr, Morgantown, WV 26505-9158Department of DermatologySchool of MedicinePO Box 91581 Medical Center DrMorgantownWV26505-9158
Key words : immunotherapy, necrolysis, PD-1, PDL-1, Stevens-Johnson syndrome, toxic epidermal
| Funding sources: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: IRB review not required. |
© 2024
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 91 - N° 5
P. 948-949 - novembre 2024 Ritorno al numero
Articolo precedente
- Types and severity of cutaneous toxicities to BRAF inhibitors are drug-specific and discrete: A single-center cohort study
- Priya Sarlashkar, Jennifer G. Gill, Meghan Heberton
- Association of inflammatory bowel disease incidence with isotretinoin usage: A meta-analysis and systematic review
- Areeba Ahmed, Ayesha Liaquat, Saamia Raza, Eric Koza, Melissa Ma, Misha Haq, Victoria Shi, Ashhad Rabeegh, Michael D. Yi, Umer Nadir, Brian A. Cahn, Ross Pearlman, Daniel I. Schlessinger, Murad Alam
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?